CRISPR Therapeutics AG
NASDAQ:CRSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
CH |
Intrinsic Value
The intrinsic value for
CRISPR Therapeutics AG (CRSP) under the Base Case is 6.21 USD.
Compared with the current market price of 54.19 USD, the stock appears
Overvalued by 89% .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for CRISPR Therapeutics AG.
Fundamental Analysis
Revenue & Expenses Breakdown
CRISPR Therapeutics AG
Earnings Waterfall
CRISPR Therapeutics AG
The intrinsic value for
CRISPR Therapeutics AG (CRSP) under the Base Case is 6.21 USD.
Compared with the current market price of 54.19 USD, the stock appears Overvalued by 89% .